House of Commons Standing Committee on Health

House of Commons Standing Committee on Health
Name	House of Commons Standing Committee on Health
Abbreviation	HESA (note: HESA is actually Education; committee has no common abbreviation)
Formation	1980s
Status	active
Headquarters	Ottawa
Leader title	Chair
Parent organization	House of Commons of Canada

House of Commons Standing Committee on Health is a committee of the House of Commons of Canada responsible for scrutinizing federal matters related to public health, health professions, pharmaceuticals, and health research. It conducts studies, holds hearings with witnesses from national and provincial institutions, and issues reports that inform policy debates in Parliament. The committee interacts with federal departments, agencies, and external stakeholders including universities, hospitals, and international organizations.

Mandate and Jurisdiction

The committee's formal remit covers the portfolio of the Minister of Health (Canada), including oversight of agencies such as Health Canada, the Public Health Agency of Canada, and the Canadian Institutes of Health Research. Its jurisdiction encompasses topics tied to specific statutes like the Food and Drugs Act, the Controlled Drugs and Substances Act, and the Safe Food for Canadians Act, as well as programs administered by Crown corporations and federal departments. The committee engages with representatives from Crown corporations such as the Canadian Broadcasting Corporation only when matters intersect with health policy, and it summons witnesses from institutions including the Royal Canadian Mounted Police, the Correctional Service of Canada, and the Immigration, Refugees and Citizenship Canada when public health implications arise. It examines interactions between federal responsibilities and provincial authorities like Ontario, Quebec, British Columbia, and Alberta governments, as well as with territorial administrations in Yukon, Northwest Territories, and Nunavut.

Membership and Structure

Membership comprises Members of Parliament drawn from parties represented in the House of Commons of Canada including the Liberal Party of Canada, the Conservative Party of Canada, the New Democratic Party, the Bloc Québécois, and representatives from smaller groups when applicable. Chairs are typically elected by committee members in accordance with House rules modeled on procedures from the Standing Orders of the House of Commons. The committee's clerk provides procedural advice similar to officials serving other committees such as the Standing Committee on Public Accounts and coordinates with the Library of Parliament and the Parliamentary Budget Officer. Meetings occur in committee rooms on Parliament Hill in Ottawa and may include attendance by parliamentary staff, research officers, and legal counsel from the Department of Justice Canada.

Activities and Subcommittees

The committee organizes full committee meetings, panel hearings, and roundtable discussions with experts from institutions including University of Toronto, McGill University, University of British Columbia, University of Alberta, and McMaster University. It may create ad hoc working groups or subcommittees to focus on specific issues such as drug safety, indigenous health, or pandemic preparedness, coordinating with bodies like the Assembly of First Nations, the Métis National Council, and Inuit Tapiriit Kanatami. The committee collaborates with regulatory bodies such as the College of Physicians and Surgeons of Ontario, the Pharmacy Examining Board of Canada, and professional associations including the Canadian Medical Association, the Canadian Nurses Association, and the Canadian Pharmacists Association. International engagement includes exchanges with the World Health Organization, the Pan American Health Organization, and parliamentary counterparts in the United Kingdom, the United States, Australia, and members of the European Union delegations.

Studies, Reports, and Recommendations

Regular studies cover topics like pharmaceutical pricing, drug shortages, mental health services, long-term care, and responses to infectious disease outbreaks. The committee issues reports with recommendations to the Minister of Health (Canada)],] federal agencies, and Parliament; recommendations frequently address coordination with provincial ministries such as Ministry of Health and Long-Term Care (Ontario), workforce planning with institutions like the Canadian Institute for Health Information, and funding mechanisms involving the Canada Health Transfer. Witnesses have included leaders from St. Michael's Hospital, Sunnybrook Health Sciences Centre, BC Cancer Agency, and research institutes such as the Hospital for Sick Children Research Institute. Studies often reference international standards set by entities like the Centers for Disease Control and Prevention, the European Medicines Agency, and the Food and Drug Administration (United States).

Legislative Review and Policy Influence

The committee conducts clause-by-clause review of health-related bills referred by the Standing Orders of the House of Commons, providing amendments and recommendations on legislation such as amendments to the Food and Drugs Act or initiatives affecting the Canada Health Act. Its scrutiny influences budget allocations debated in supply days and estimates processes overseen by committees like the Standing Committee on Procedure and House Affairs and the Standing Committee on Public Accounts. Through public testimony and reports, the committee shapes debates in the House of Commons of Canada and informs ministerial responses, intergovernmental accords including the Health Accord (2004), and federal policy frameworks discussed with provincial premiers such as the Premiers of Canada's Provinces and Territories.

History and Notable Inquiries

Since its establishment, the committee has conducted high-profile inquiries into pandemic readiness, vaccine procurement, opioid crises, and long-term care failures. Notable probes have involved scrutiny of responses to the H1N1 pandemic, the COVID-19 pandemic, and drug overdose epidemics linked to synthetic opioids like fentanyl. The committee has summoned officials from Public Health Agency of Canada leadership and executives from pharmaceutical companies including Pfizer, Moderna, Johnson & Johnson, and AstraZeneca during inquiries into procurement and regulatory approval. Historic hearings have featured testimony referencing public health events such as the SARS outbreak, inquiries like the Commission of Inquiry into the 1998 Outbreak of Escherichia coli O157:H7 in Walkerton, and interactions with coroners and provincial inquiries including those in Quebec and Ontario. Its reports have been cited in legislative debates alongside work by think tanks and NGOs such as the Canadian Institute for Health Information, the Fraser Institute, the Canadian Centre for Policy Alternatives, and advocacy groups like Canadian Doctors for Medicare.

Category:Parliament of Canada